TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Trading 06-25 14:01:17 EDT

77.19

-0.43

-0.55%

High80.25	Low76.89	Vol511.39K
Open77.62	D1 Closing77.62	Amplitude4.33%
Mkt Cap2.67B	Tradable Cap2.54B	Total Shares34.54M
T/O40.20M	T/O Rate1.55%	Tradable Shares32.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":77.185,"timestamp":1782410476170,"preClose":77.615,"halted":0,"volume":511385,"delay":0,"changeRate":-0.005540166204986055,"floatShares":32954993,"shares":34544158,"eps":4.465339,"marketStatus":"Trading","change":-0.43,"latestTime":"06-25 14:01:17 EDT","open":77.62,"high":80.25,"low":76.89,"amount":40202659.62125,"amplitude":0.043291,"askPrice":77.32,"askSize":126,"bidPrice":77.09,"bidSize":103,"shortable":3,"etf":0,"ttmEps":4.465339,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1782417600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":77.615,"preHourTrading":{"tag":"盘前","latestPrice":78.2,"preClose":77.615,"latestTime":"09:19 EDT","volume":2168,"amount":169031.45872,"timestamp":1782393590141,"change":0.585,"changeRate":0.007537,"amplitude":0.017394},"postHourTrading":{"tag":"盘后","latestPrice":78,"preClose":77.615,"latestTime":"19:53 EDT","volume":30952,"amount":2400611.3244,"timestamp":1782345215760,"change":0.385,"changeRate":0.00496,"amplitude":0.009019},"volumeRatio":0.692851,"impliedVol":0.7389,"impliedVolPercentile":0.6813},"requestUrl":"/m/hq/s/TMDX/tweets","defaultTab":"tweets","newsList":[{"id":"2645801064","title":"Stifel Nicolaus Sticks to Their Hold Rating for TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645801064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645801064?lang=en_us&edition=fundamental","pubTime":"2026-06-22 10:15","pubTimestamp":1782094541,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Thomas Stephan from Stifel Nicolaus maintained a Hold rating on TransMedics Group, with a price target of $80.00. S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-hold-rating-for-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-hold-rating-for-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644297457","title":"TransMedics Director Thomas J. Gunderson disposes of USD 722,599.44 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644297457","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644297457?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:15","pubTimestamp":1781727355,"startTime":"0","endTime":"0","summary":"TransMedics director Thomas J. Gunderson exercised stock options on June 15, 2026, acquiring 19,285 common shares at USD 2.21.He sold 9,624 common shares the same day at USD 75.06, cutting his stake to 16,642 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL5SZX46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Director Thomas J. Gunderson disposes of USD 722,599.44 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX","LU2065731478.USD","BK4585","LU2324357040.USD","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643113702","title":"Does TransMedics (TMDX) Margin Pressure And Legal Review Hint At A Shifting Risk Profile?","url":"https://stock-news.laohu8.com/highlight/detail?id=2643113702","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643113702?lang=en_us&edition=fundamental","pubTime":"2026-06-13 14:21","pubTimestamp":1781331690,"startTime":"0","endTime":"0","summary":"Earlier this week, Johnson Fistel, PLLP announced an investigation into TransMedics Group following past disclosures that its National OCS Program investments coincided with rising costs and pressure on gross and operating margins, despite revenue growth.\nThis combination of margin compression and a fresh legal review of the company’s disclosures introduces an additional layer of uncertainty around how TransMedics balances growth investments with profitability and regulatory...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/does-transmedics-tmdx-margin-pressure-and-legal-review-hint","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/does-transmedics-tmdx-margin-pressure-and-legal-review-hint","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TMDX","LU2065731478.USD","BK4082","BK4588","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642461295","title":"Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Erasca (ERAS) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642461295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642461295?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:40","pubTimestamp":1781001614,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Erasca (ERAS) and Incyte (INCY). TransM...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-transmedics-group-tmdx-erasca-eras-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-transmedics-group-tmdx-erasca-eras-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4139","BK4137","XBI","ERAS","BK4082","BK4532","BK4588","BK4585","TMDX","LU2065731478.USD","BK4581","BK4550","HCSG","INCY","LABU","BK4539","XLV","LU2324357040.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641005144","title":"Analysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641005144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641005144?lang=en_us&edition=fundamental","pubTime":"2026-06-06 02:12","pubTimestamp":1780683155,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and TransMedics Group (TMDX...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-charles-river-labs-crl-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-charles-river-labs-crl-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4530","BK4082","LU0128526141.USD","BK4585","LU1815336091.USD","LU0029874061.USD","LU0390134368.USD","TMDX","CRL","LU0757428866.USD","BK4588","LU2324357040.USD","BK4121","IE00BFMHRM44.USD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640188830","title":"TransMedics publishes investor presentation on Organ Care System platform, national procurement and transplant logistics network","url":"https://stock-news.laohu8.com/highlight/detail?id=2640188830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640188830?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:41","pubTimestamp":1780497676,"startTime":"0","endTime":"0","summary":"TransMedics publishes investor presentation on Organ Care System platform, national procurement and transplant logistics network. TransMedics outlined plans to scale its Organ Care System platform toward 20,000+ annual OCS transplants, supported by new programs and international expansion.FY26 revenue guidance set at USD 727 million to USD 757 million, implying 20% to 25% growth.Cash balance of USD 461.7 million as of March 31, 2026.U.S. infrastructure highlighted at 19 clinical hubs, 22 dedicated planes, 50+ procurement surgeons.Registry utilization rates cited at 96% for lungs, 97% for hearts, 98% for livers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this new","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDLbCtZcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TMDX","BK4585","LU2065731478.USD","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640481479","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Climb Bio (CLYM) and TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640481479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640481479?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:11","pubTimestamp":1780402267,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kymera Therapeutics (KYMR), Climb Bio (CLYM) and T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-climb-bio-clym-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-climb-bio-clym-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","CLYM","LU2324357040.USD","BK4139","KYMR","LU0029874061.USD","HCSG","LU0128526141.USD","XBI","LU2065731478.USD","BK4539","BK4082","TMDX","BK4581","BK4588","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638549856","title":"Assessing TransMedics Group (TMDX) Valuation After A Sharp Multi Month Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2638549856","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638549856?lang=en_us&edition=fundamental","pubTime":"2026-05-28 12:30","pubTimestamp":1779942633,"startTime":"0","endTime":"0","summary":"TransMedics Group stock: recent performance snapshot\nTransMedics Group (TMDX) has drawn fresh attention after a steep pullback, with the stock down about 35% over the past month and roughly 48% over the past 3 months based on recent total returns.\nSee our latest analysis for TransMedics Group.\nAt a share price of $70.15, TransMedics Group’s short term momentum has cooled, with the 30 day share price return declining about 35% and the 90 day share price return down around 48%, even though the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/assessing-transmedics-group-tmdx-valuation-after-a-sharp-mul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/assessing-transmedics-group-tmdx-valuation-after-a-sharp-mul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4082","LU2324357040.USD","TMDX","BK4588","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638779546","title":"TransMedics Group Is Maintained at Hold by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2638779546","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638779546?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:05","pubTimestamp":1779811500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 12:05 ET (16:05 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","SF","BK4127","TMDX","BK4588","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515717","title":"Transmedics Group Inc : Stifel Cuts Target Price to $75 From $85","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515717?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:45","pubTimestamp":1779792343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN42306W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4585","BK4588","LU2324357040.USD","TMDX","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637354635","title":"TransMedics shareholders approved amended 2019 stock incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637354635","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637354635?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:17","pubTimestamp":1779394678,"startTime":"0","endTime":"0","summary":"TransMedics Group held its annual shareholder meeting on May 20, 2026.Eight directors were chosen to serve until the 2027 annual meeting.Shareholders backed an amendment to the company’s 2019 Stock Incentive Plan, authorizing the plan change but not confirming any issuance or grants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6HJL83:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2065731478.USD","BK4082","TMDX","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637255351","title":"TransMedics grants inducement equity awards to 14 new employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2637255351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637255351?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:06","pubTimestamp":1779393960,"startTime":"0","endTime":"0","summary":"TransMedics granted inducement equity awards on May 19, 2026, issuing non-qualified stock options for 37,367 shares and 24,848 restricted stock units to 14 new employees.Senior Vice President, General Counsel & Corporate Secretary Matthew S. Forsyth received options covering 23,171 shares and 15,409 restricted stock units.The options carry an exercise price of USD 66.13 per share, matching the stock’s May 19 close, with 25% vesting on the first anniversary of the start date and the balance vesting monthly over the next three years; the term is 10 years.Restricted stock units vest 25% on each of the first four anniversaries of the start date.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6SJ50V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","LU2324357040.USD","TMDX","BK4585","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636861273","title":"TransMedics presents at William Blair Growth Stock Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636861273","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636861273?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:05","pubTimestamp":1779221136,"startTime":"0","endTime":"0","summary":"TransMedics will present at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026.The presentation is scheduled to start at 2:20 p.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL9cZ8bv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TMDX","LU2065731478.USD","BK4082","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634941622","title":"Does TransMedics (TMDX) Revenue Growth And OCS Adoption Clarify Or Complicate Its Profitability Path?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634941622","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634941622?lang=en_us&edition=fundamental","pubTime":"2026-05-09 22:31","pubTimestamp":1778337102,"startTime":"0","endTime":"0","summary":"In early May 2026, TransMedics Group reported first-quarter revenue of US$173.93 million, up from US$143.54 million a year earlier, while net income decreased to US$7.32 million as spending rose, and it reiterated full-year 2026 revenue guidance of US$727 million to US$757 million.\nA key development was the adoption of TransMedics’ Organ Care System Heart at the Montreal Heart Institute and CHU Sainte-Justine, highlighting expanding clinical use of its transplant technology in real-world...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/does-transmedics-tmdx-revenue-growth-and-ocs-adoption-clarif","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/does-transmedics-tmdx-revenue-growth-and-ocs-adoption-clarif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TMDX","OCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193056","title":"TransMedics price target lowered to $142 from $174 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193056?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:53","pubTimestamp":1778126015,"startTime":"0","endTime":"0","summary":"Needham lowered the firm’s price target on TransMedics (TMDX) to $142 from $174 and keeps a Buy rating on the shares. The company’s Q1 revenue and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-142-from-174-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-142-from-174-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LU2065731478.USD","BK4082","BK4588","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193661","title":"TransMedics falls -20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193661?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:40","pubTimestamp":1778125251,"startTime":"0","endTime":"0","summary":"TransMedics (TMDX) is down -20.5%, or -$19.43 to $75.50. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-falls-20-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-falls-20-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","BK4588","TMDX","BK4082","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633155486","title":"TransMedics Down Over 25%, On Track for Largest Percent Decrease Since October 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2633155486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633155486?lang=en_us&edition=fundamental","pubTime":"2026-05-07 02:49","pubTimestamp":1778093340,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc.  is currently at $70.77, down $24.16 or 25.45%. --Would be lowest close since April 8, 2025, when it closed at $67.95. --On pace for largest percent decrease since Oct. 29, 2024, when it fell 29.9%. --Currently down four consecutive days; down 29.78% over this period. --Longest losing streak since April 29, 2026, when it fell for five straight trading days. --Down 59.81% from its all-time closing high of $176.11 on Aug. 27, 2024. --Down 26.13% from 52 weeks ago , when it closed at $95.81. --Traded as low as $70.35; lowest intraday level since April 9, 2025, when it hit $66.85. --Down 25.89% at today's intraday low; largest intraday percent decrease since Oct. 29, 2024, when it fell as much as 32.27%","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","LU2324357040.USD","LU2065731478.USD","TMDX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107651176","title":"Stock Track | TransMedics Group Plummets 24.28% Intraday After Q1 Earnings Severely Miss Estimates, Prompting Analyst Downgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1107651176","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107651176?lang=en_us&edition=fundamental","pubTime":"2026-05-07 00:16","pubTimestamp":1778084188,"startTime":"0","endTime":"0","summary":"TransMedics Group, Inc. (TMDX) experienced a sharp intraday decline of 24.28% on Wednesday, as the medical technology company's stock came under significant selling pressure following the release of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139497","title":"Needham Adjusts Price Target on TransMedics Group to $142 From $174, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139497","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139497?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:49","pubTimestamp":1778075340,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $121.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","TMDX","LU2065731478.USD","BK4082","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633133983","title":"TransMedics Group Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2633133983","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633133983?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:27","pubTimestamp":1778070420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 06, 2026 08:27 ET (12:27 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4585","TMDX","BK4588","LU2065731478.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.06},{"period":"1month","weight":0.1259},{"period":"3month","weight":-0.2406},{"period":"6month","weight":-0.3751},{"period":"1year","weight":-0.4148},{"period":"ytd","weight":-0.362}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.026649},{"month":2,"riseRate":0.714286,"avgChangeRate":0.153587},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.028866},{"month":4,"riseRate":0.714286,"avgChangeRate":0.095218},{"month":5,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":6,"riseRate":1,"avgChangeRate":0.158027},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.012617},{"month":8,"riseRate":0.571429,"avgChangeRate":0.040414},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.096617},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.026786}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}